Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding US DMF Number 38892.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2024, and payment made on September 26, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II